Thomas Marron
Clinical trials sponsored by Thomas Marron, explained in plain language.
-
New combo therapy aims to revive immune attack on tough lung cancers
Disease control OngoingThis study tests whether adding two drugs (dupilumab and anakinra) to standard immunotherapy can help shrink or control advanced non-small cell lung cancer that has stopped responding to prior immunotherapy. About 33 adults whose cancer progressed after PD-1/PD-L1 treatment will …
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
Could an HIV drug help fight resistant cancers?
Disease control OngoingThis early-phase trial tests whether adding lamivudine (an HIV drug) to standard immunotherapy can help control advanced solid tumors that have stopped responding to treatment. About 12 to 24 adults with various solid cancers will receive the combination. The goal is to check saf…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Marron • Aim: Disease control
Last updated May 19, 2026 12:00 UTC